Color Health · Series D
Reinventing cancer care with direct clinical access, speed, and expert support for better outcomes and lower costs.
Amount
$75M
Round
Series D
Valuation
—
Announced
Jan 2020
Investors
Lead investor
T. Rowe PriceParticipating investors